BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 28688696)

  • 1. Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma.
    Kim TH; Kim YN; Kim HI; Park SY; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Kim K; Jeong JG; Kim SW; Chung JH
    Oral Oncol; 2017 Aug; 71():81-86. PubMed ID: 28688696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
    Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
    Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reassessment of Differentiated Thyroid Cancer Patients Using the Eighth TNM/AJCC Classification System: A Comparative Study.
    Shteinshnaider M; Muallem Kalmovich L; Koren S; Or K; Cantrell D; Benbassat C
    Thyroid; 2018 Feb; 28(2):201-209. PubMed ID: 29256827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.
    van Roessel S; Kasumova GG; Verheij J; Najarian RM; Maggino L; de Pastena M; Malleo G; Marchegiani G; Salvia R; Ng SC; de Geus SW; Lof S; Giovinazzo F; van Dam JL; Kent TS; Busch OR; van Eijck CH; Koerkamp BG; Abu Hilal M; Bassi C; Tseng JF; Besselink MG
    JAMA Surg; 2018 Dec; 153(12):e183617. PubMed ID: 30285076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.
    Lang B; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 May; 14(5):1551-9. PubMed ID: 17318278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.
    Zhi J; Wu Y; Hu L; Zhao J; Liu H; Ruan X; Hou X; Zhang J; Zheng X; Gao M
    Int J Clin Oncol; 2020 Jan; 25(1):59-66. PubMed ID: 31414270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Validation of the Prognostic Stage Groups of the Eighth-Edition TNM Staging for Medullary Thyroid Carcinoma.
    Park SY; Cho YY; Kim HI; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Kim K; Kim SW; Chung JH; Kim TH
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4609-4616. PubMed ID: 30137493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
    Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
    Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Seventh and Eighth Editions of the American Joint Committee on Cancer/Union for International Cancer Control Tumor-Node-Metastasis Staging System for Differentiated Thyroid Cancer.
    Kim M; Kim WG; Oh HS; Park S; Kwon H; Song DE; Kim TY; Shong YK; Kim WB; Sung TY; Jeon MJ
    Thyroid; 2017 Sep; 27(9):1149-1155. PubMed ID: 28635571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the predicted impact of changes to the AJCC/TMN staging system for differentiated thyroid cancer (DTC): A prospective observational study of patients in South East Scotland.
    Hulse K; Williamson A; Gibb FW; Conn B; Nixon IJ
    Clin Otolaryngol; 2019 May; 44(3):330-335. PubMed ID: 30720920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis.
    Kim HI; Kim K; Park SY; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Ahn HS; Kim SW; Kim TH; Chung JH
    Oral Oncol; 2018 Mar; 78():80-86. PubMed ID: 29496063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.
    Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S
    Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Does The AJCC/TNM Staging System Eighth Edition Perform in Thyroid Cancer at A Major Middle Eastern Medical Center?
    Alzahrani AS; Albalawi L; Mazi S; Mukhtar N; Aljamei H; Moria Y; Elsayed T; Amer L; Alanazi F; Alnasser L; Alqarni B; Fadel R; AlMatar A; Alqahtani A; Tuttle RM
    Endocr Pract; 2021 Jun; 27(6):607-613. PubMed ID: 34120701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system.
    Chereau N; Oyekunle TO; Zambeli-Ljepović A; Kazaure HS; Roman SA; Menegaux F; Sosa JA
    Br J Surg; 2019 Jun; 106(7):889-897. PubMed ID: 31012500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No significant difference in the prognostic value of the 5th and 7th editions of AJCC staging for differentiated thyroid cancer.
    Vrachimis A; Gerss J; Stoyke M; Wittekind C; Maier T; Wenning C; Rahbar K; Schober O; Riemann B
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):911-7. PubMed ID: 24417487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the American Joint Committee on Cancer eighth edition staging system in patients undergoing hepatectomy for hepatocellular carcinoma: a US population-based study.
    Zhang G; Li R; Zhao X; Meng S; Ye J; Zhao L
    J Surg Res; 2018 Feb; 222():55-68. PubMed ID: 29273376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refining the tumor-node-metastasis staging system for individualized treatment of differentiated thyroid carcinoma.
    Kim YN; Kim M; Ahn HS; Kim K; Park SY; Kim HI; Jeon MJ; Kim WG; Kim SW; Kim WB; Chung JH; Shong YK; Kim TY; Kim TH
    Oral Oncol; 2019 Feb; 89():8-13. PubMed ID: 30732964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
    Ghaznavi SA; Ganly I; Shaha AR; English C; Wills J; Tuttle RM
    Thyroid; 2018 Oct; 28(10):1293-1300. PubMed ID: 29897011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non-small-cell Lung Cancer.
    Chen K; Chen H; Yang F; Sui X; Li X; Wang J
    Clin Lung Cancer; 2017 Nov; 18(6):e457-e466. PubMed ID: 28539214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.